Angioid streaks are a rare condition in which small, dark lines form on the retina of the eye. These streaks are caused by a weakening of the tissue that supports the retina, allowing the blood vessels to form a pattern that resembles a web. While the cause of angioid streaks is still largely unknown, they can have a significant impact on vision and can lead to blindness if left untreated. In this article, we will explore the mystery of angioid streaks, looking at the causes, effects, and treatments.
Angioid streaks are dark lines that form on the retina of the eye, typically in a pattern that resembles a web. These streaks are caused by a weakening of the tissue that supports the retina, allowing the blood vessels to form a pattern that resembles a web. The condition is rare, affecting only about one in every 10,000 people.
The exact cause of angioid streaks is still largely unknown. However, it is believed that the condition is linked to certain conditions and diseases, such as Paget's disease, pseudoxanthoma elasticum, sickle cell anemia, and Ehlers-Danlos syndrome. It is also believed that certain medications, such as isotretinoin (Accutane), can increase the risk of developing angioid streaks.
The effects of angioid streaks can vary from person to person. In some cases, the streaks may cause no symptoms and can go unnoticed. In other cases, the streaks can cause vision problems, such as blurred vision, difficulty seeing in low light, and blind spots. In severe cases, the streaks can lead to blindness.
Angioid streaks can be diagnosed through a comprehensive eye exam. During the exam, your doctor will use a special device called an ophthalmoscope to look at the back of your eye and check for any signs of angioid streaks. If angioid streaks are detected, your doctor will likely recommend treatment to reduce the risk of vision loss. Treatment may include medication, such as anti-inflammatory drugs, to reduce swelling and improve vision. In severe cases, surgery may be recommended to remove the streaks and improve vision.
Since the exact cause of angioid streaks is still largely unknown, it is difficult to prevent the condition from occurring. However, there are some steps you can take to reduce your risk. For example, it is important to maintain good overall health and to follow your doctor's instructions if you are taking any medications that could increase your risk of developing angioid streaks.
Angioid streaks are a rare condition in which dark lines form on the retina of the eye. While the cause of angioid streaks is still largely unknown, the condition can have a significant impact on vision and can lead to blindness if left untreated. Diagnosis and treatment of angioid streaks can help reduce the risk of vision loss. While there is no sure way to prevent the condition, maintaining good overall health and following your doctor's instructions can help reduce your risk.
1.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
4.
A prostate cancer risk prediction algorithm could help target men at highest risk
5.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
1.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
2.
Bone Marrow Regeneration in Hematologic Recovery
3.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
4.
Iron Homeostasis Throughout the Female Lifespan
5.
Demystifying Lymphocytes: Everything You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation